The abrupt termination last month of nearly half a billion dollars in US government contracts for mRNA vaccine research ...

Clinical studies suggest these vaccines can generate immunological memory, allowing lymphocytes to respond to tumor ...

In September 2025, the Russian Federal Medical and Biological Agency announced that its mRNA-based vaccine Enteromix had ...

New vaccine shows promise in curing deadly allergies, scientists say - Researchers say vaccine prevents allergens from ...

The Department of Defense funds biomedical research to ensure military and pandemic preparedness. This includes mRNA vaccine ...

U.S. defense supports mRNA vaccine development as health department withdraws funding U.S. defense agency backs mRNA vaccine ...

"As US funding falters, mRNA cancer vaccine pioneers face new hurdles" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

BARDA is canceling $500 million of contracts to develop mRNA vaccines for flu and COVID (HHS) Secretary Robert F. Kennedy Jr.

CHARLESTON, S.C. (WCSC) - The Trump administration started to cut funding from messenger ribonucleic acid vaccine research earlier this month, impacting more than 20 contracts for vaccine development.

While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...